Lemaitre Vascular Inc
- Last sale
- Nov 6, 2026 · -3.18%
- Market cap
- $1.85B
- 22.88M shares
- Filings
- 1,036
Q3 2026+13.5% FY25 yoy
Q3 2026+31.1% FY25 yoy
Q3 2026+30.0% FY25 yoy
Q3 2026derived+100.4% FY25 yoy
Q3 2026+30.6% FY25 yoy
Q3 2026+10.3% FY25 yoy
- $1.85B
- 29.2×
- 6.9×
- 4.3×
- 3.62%
- 1.17%
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $249,602,000 | reported | |
| FY 2024 | 2024-12-31 | $219,863,000 | reported | |
| FY 2023 | 2023-12-31 | $193,484,000 | reported | |
| FY 2022 | 2022-12-31 | $161,651,000 | reported | |
| FY 2021 | 2021-12-31 | $154,424,000 | reported | |
| FY 2020 | 2020-12-31 | $129,366,000 | reported | |
| FY 2019 | 2019-12-31 | $117,232,000 | reported | |
| FY 2018 | 2018-12-31 | $105,568,000 | reported | |
| FY 2017 | 2017-12-31 | $100,867,000 | reported | |
| FY 2016 | 2016-12-31 | $89,151,000 | reported | |
| FY 2015 | 2015-12-31 | $78,352,000 | reported | |
| FY 2014 | 2014-12-31 | $71,097,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $18.11M | $1.82M | $19.93M | $0.80 | 22.78M sh | +1.0% | 26.8% |
| FY2024 | $14.38M | $1.72M | $16.10M | $0.64 | 22.56M sh | +1.0% | 43.3% |
| FY2023 | $12.45M | $853.00K | $13.30M | $0.56 | 22.34M sh | +1.1% | 45.1% |
| FY2022 | $10.99M | $642.00K | $11.63M | $0.50 | 22.10M sh | +0.8% | 52.5% |
| FY2021 | $9.34M | $802.00K | $10.14M | $0.44 | 21.93M sh | +6.8% | 33.5% |
Segments
Geography
LineFY2025ShareChange
United States$141.57M57%+10.0%
Other countries$61.67M25%+18.4%
Germany$17.90M7.2%+24.1%
Canada$15.25M6.1%+11.6%
United Kingdom$13.22M5.3%+20.6%
Other Countries———
Total$249.60M
Surgical & medical instruments & apparatus
Lemaitre Vascular Inc is the 38th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
TCMDTactile Systems Technology Inc$329.5M12.5%5.8%$601.3MANGOAngiodynamics Inc$320.2M9.5%11.5%$479.0MPRCTPROCEPT BioRobotics Corp$308.1M37.2%31.0%$1.4BSKINSkinHealth Systems Inc.$300.8M10.0%3.2%$106.2M
LMATLemaitre Vascular Inc (this company)$249.6M13.5%23.1%$1.9B
KIDSOrthopediatrics Corp$236.3M15.4%16.8%$851.7MCERSCerus Corp$233.8M16.1%6.7%$390.8MTMCITreace Medical Concepts, Inc.$212.7M1.6%27.7%$350.7MSIBNSi-Bone, Inc.$200.9M20.2%9.4%$1.1BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Lemaitre Vascular Inc · CIK 1158895 · Engraved from SEC EDGAR